Prospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Pharmacol Ther. Nov 5, 2021; 12(6): 103-112
Published online Nov 5, 2021. doi: 10.4292/wjgpt.v12.i6.103
Table 3 Colon capsule endoscopy completion vs non-completion, n (%)
Variable
Total
With castor oil
Without castor oil
P value
Overall capsule completion144/186 (77)54/62 (87)90/124 (73)0.0128
Age:
≤ 6067/78 (86)24/26 (92)43/52 (83)0.1250
> 6077/108 (71)30/36 (83)47/72 (65)0.0253
Gender:
Male68/82 (83)25/28 (89)43/54 (80)0.1352
Female76/104 (73)29/34 (85)47/70 (67)0.0251
Indication:
Polyp surveillance75/96 (78)28/30 (93)47/66 (71)0.0075
Lower gastrointestinal symptoms36/42 (86)10/10 (100)26/32 (81)0.0450
Incomplete colonoscopy19/28 (68)7/11 (63)12/17 (7)0.3502
Anaemia12/18 (67)8/10 (80)4/8 (50)0.0899
IBD surveillance2/2 (100)1/1 (100)1/1 (100)1.0